Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
1(33.3%)
N/A
1(33.3%)
Phase 4
1(33.3%)
3Total
Phase 1(1)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03289416Phase 4Completed

Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis

Role: collaborator

NCT04241354Phase 1Unknown

A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis

Role: collaborator

NCT04064866Not ApplicableCompleted

Safety and Efficacy of PRP for Treatment of Disc Pain

Role: collaborator

All 3 trials loaded